Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for phosphodiesterase 3 inhibitors (compound)
Most Correlated Studies
- Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Affymetrix]
- Drug target sets for approved compounds
- Broad Connectivity Map (CMAP 2.0) compound database
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Most Relevant Literature
- Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia-Effe…
- PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia.
- PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment.
- K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a …
- Phosphodiesterase-3 inhibitor].
Most Relevant Clinical Trials
- Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneu…
- Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneu…
- The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Ma…
- The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With …
- Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)
